Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGT1 | P19440 | 4/20 | 0.52 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.42 |
| ▸ | ARG1 | P05089 | 3/20 | 0.42 |
| ▸ | ARG2 | P78540 | 3/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.42 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.42 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29024969 | 0.76 | SLC7A5 (0.68) | GGT1SLC7A5SLC1A1SLC1A3SLC1A2 | |
| SCHEMBL600881 | 0.76 | SLC7A5 (0.68) | GGT1SLC7A5SLC1A1SLC1A3SLC1A2 | |
| SCHEMBL9545322 | 0.76 | SLC7A5 (0.68) | GGT1SLC7A5SLC1A1SLC1A3SLC1A2 | |
| Hydrochloric Acid SCHEMBL8892666 | 0.73 | SLC7A5 (0.65) | GGT1SLC7A5SLC1A1SLC1A3SLC1A2 | |
| Leucine SCHEMBL2127045 | 0.71 | SLC7A5 (0.86) | GGT1SLC7A5SLC1A1SLC1A3SLC1A2 | |
| Leucine SCHEMBL2127042 | 0.71 | SLC7A5 (0.86) | GGT1SLC7A5SLC1A1SLC1A3SLC1A2 | |
| SCHEMBL445471 | 0.71 | SLC7A5 (0.62) | GGT1SLC7A5SLC1A1SLC1A3SLC1A2 | |
| SCHEMBL6232483 | 0.71 | SLC7A5 (0.62) | GGT1SLC7A5SLC1A1SLC1A3SLC1A2 | |
| SCHEMBL4303994 | 0.71 | SLC7A5 (0.62) | GGT1SLC7A5SLC1A1SLC1A3SLC1A2 | |
| SCHEMBL148584 | 0.71 | SLC7A5 (0.62) | GGT1SLC7A5SLC1A1SLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129557-B2 | Phosphonic acid diester derivative and method for producing thereof | Nagai, Kazuhiro (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20090163725-A1 | PHOSPHONIC ACID DIESTER DERIVATIVE AND METHOD FOR PRODUCING THEREOF | HIRATAKE, GOU (JP) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163725-A1 | PHOSPHONIC ACID DIESTER DERIVATIVE AND METHOD FOR PRODUCING THEREOF | PPA1, G6PD, PHOSPHO1 | GGT1 362/4885SLC7A5 3382/4885SLC1A1 3907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.